MAPT and Alzheimer disease: This has brought increased attention to the tau hypothesis, which theorizes that tau is the initiator of downstream AD neurodegeneration via pathologic modifications, like hyperphosphorylation, that make the protein prone to aggregation and prion-like propagation [7, 8, 154].